Global Patent Index - EP 1235580 A2

EP 1235580 A2 2002-09-04 - TRANSDERMAL SYSTEM CONTAINING ACETYLSALICYLIC ACID FOR TREATMENT OF MIGRAINE

Title (en)

TRANSDERMAL SYSTEM CONTAINING ACETYLSALICYLIC ACID FOR TREATMENT OF MIGRAINE

Title (de)

ACETYLSALICYLSÄURE ENTHALTENDES TRANSDERMALES SYSTEM ZUR BEHANDLUNG VON MIGRÄNE

Title (fr)

SYSTEME TRANSDERMIQUE CONTENANT DE L'ACIDE ACETYLSALICYLIQUE POUR LE TRAITEMENT DE LA MIGRAINE

Publication

EP 1235580 A2 (DE)

Application

EP 00987336 A

Priority

  • DE 19959913 A
  • EP 0012092 W

Abstract (en)

[origin: WO0141771A2] The use of acetylsalicylic acid for the treatment of migraine and other serotonin-dependent, thrombocyte-mediated diseases is characterised in that the effective agent is administered by means of a transdermal therapeutic system (TTS).

IPC 1-7 (main, further and additional classification)

A61K 31/616; A61K 9/70; A61P 25/06

IPC 8 full level (invention and additional information)

A61K 9/70 (2006.01); A61K 31/60 (2006.01); A61K 31/616 (2006.01); A61K 45/00 (2006.01); A61P 25/06 (2006.01); A61P 43/00 (2006.01)

CPC (invention and additional information)

A61K 9/7061 (2013.01); A61K 31/616 (2013.01)

Citation (search report)

See references of WO 0141771A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

EPO simple patent family

WO 0141771 A2 20010614; WO 0141771 A3 20011227; AU 2361801 A 20010618; CA 2393748 A1 20010614; DE 19959913 A1 20010628; EP 1235580 A2 20020904; JP 2003516356 A 20030513; US 2003008852 A1 20030109

INPADOC legal status


2004-08-25 [18W] WITHDRAWN

- Effective date: 20040616

2002-10-02 [RIN1] INVENTOR (CORRECTION)

- Inventor name: FRANKE, HANSHERMANN

2002-10-02 [RIN1] INVENTOR (CORRECTION)

- Inventor name: ASMUSSEN, BODO

2002-09-04 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20020604

2002-09-04 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR